Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane.

Oncology

Volumn 67, Issue 5-6, 2004, Pages 376-381

  Raspagliesi, Francesco ^a   Zanaboni, Flavia ^a   Vecchione, Francesca ^a   Hanozet, Francesco ^a   Scollo, Paolo ^a   Ditto, Antonino ^a   Grijuela, Barbara ^a   Fontanelli, Rosanna ^a   Solima, Eugenio ^a   Spatti, Gianbattista ^a   Scibilia, Giuseppe ^a   Kusamura, Shigeki ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; OXALIPLATIN; PLATINUM COMPLEX; PLATINUM DERIVATIVE; TAXOID;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG RESISTANCE; FEASIBILITY STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MULTICENTER STUDY; NEUTROPENIA; OVARY TUMOR; PATHOLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEUTROPENIA; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; SEVERITY OF ILLNESS INDEX; TAXOIDS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 13844315461     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082921     Document Type: Article

References (0)